Calliditas Announces Late-Breaking Presentations at the 60th European Renal Association (ERA) Congress 2023 May 5, 2023 14:30 CET Non Regulatory Read more
Calliditas to participate in upcoming investor conferences March 31, 2023 17:00 CET Non Regulatory Read more
Calliditas Receives Conditional Marketing Authorization from UK MHRA for Kinpeygo in IgA nephropathy February 2, 2023 09:15 CET Non Regulatory Read more
